Key statistics
On Monday, Bio-Techne Corp (TE1:FRA) closed at 49.00, 20.69% above the 52 week low of 40.60 set on May 22, 2025.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 48.80 |
|---|---|
| High | 49.00 |
| Low | 48.80 |
| Bid | -- |
| Offer | -- |
| Previous close | 49.20 |
| Average volume | 296.60 |
|---|---|
| Shares outstanding | 156.45m |
| Free float | 155.39m |
| P/E (TTM) | 116.24 |
| Market cap | 9.23bn USD |
| EPS (TTM) | 0.5076 USD |
| Annual div (ADY) | 0.2696 EUR |
|---|---|
| Annual div yield (ADY) | 0.55% |
| Div ex-date | Feb 13 2026 |
| Div pay-date | Feb 27 2026 |
Data delayed at least 15 minutes, as of Mar 02 2026 20:47 GMT.
More ▼
Press releases
- Bio-Techne to Present at Upcoming Investor Conferences
- Bio-Techne's Ella Platform Achieves CE-IVD Marking Expanding Access to Rapid, Cartridge‑Based Immunoassays for European Clinical Laboratories
- Bio-Techne Announces Changes to its Leadership Team
- Bio-Techne Releases Second Quarter Fiscal 2026 Results
- Bio-Techne Declares Dividend
- Bio-Techne Expands 3D Stem Cell and Organoid Culture Portfolio with a Fully Defined Synthetic Alternative
- Bio-Techne Launches Simple Plex Ultra-Sensitive Assays on Ella Platform to Enable Femtogram-Level Detection of Neurological Biomarkers
- Bio-Techne to Host Conference Call on February 4, 2026, to Announce Second Quarter Fiscal 2026 Financial Results
- Bio-Techne to Present at the 2026 J.P. Morgan Healthcare Conference
- Bio-Techne Partners with the Wyss Center Geneva to Advance Automated 3D Multiomics Technology and Accelerate Spatial Biology
More ▼
